Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. Founded by Hannu Rajaniemi, Nikolai Eroshenko in 2013, HelixNano is backed by investors that include Fifty Years, Data Collective DCVC, Charlie Songhurst, Lifeline Ventures, and Nordic Makers and is headquartered in Cambridge.